RemSleep Holdings Inc. Provides a Shareholder Update
March 28, 2022 08:35 ET
|
RemSleep Holdings, Inc.
Tampa, FL, March 28, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep...
RemSleep Holdings Announces Significant Distribution Agreement for Nasal CPAP Machines to Address USA CPAP Shortage
March 22, 2022 08:00 ET
|
RemSleep Holdings, Inc.
Tampa, FL, March 22, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep...
ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day
March 14, 2022 09:00 ET
|
ResMed Inc.
Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at nightQuality and quantity of sleep have benefitted from remote working, and many are concerned waking...
RemSleep Holdings Inc Announces Engagement of New Investor Relations Firm and News Distributor
January 24, 2022 09:00 ET
|
RemSleep Holdings, Inc.
Tampa, FL, Jan. 24, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep...
Sleep Disorder Market revenue to cross USD 20.5 Bn by 2027: Global Market Insights Inc.
January 12, 2022 06:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The sleep disorder market size is anticipated to record a valuation of USD 20.5 billion by 2027, according to the most recent study by...
ProSomnus® Sleep Technologies Adds John Remmers, MD, to Leadership Team
September 27, 2021 11:00 ET
|
ProSomnus Sleep Technologies
SAN FRANCISCO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies, the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced...
ResMed Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatment
August 16, 2021 09:00 ET
|
ResMed Inc.
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea treatment, (NYSE: RMD, ASX: RMD) today launched AirSense 11, available first in the U.S., the...
InvestorBrandNetwork Announces Relentless Dentist Podcast Featuring Vivos Therapeutics Inc. CEO R. Kirk Huntsman
June 09, 2021 08:00 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, June 09, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
Vivos Therapeutics to Participate at the Q1 Virtual Investor Summit
March 11, 2021 07:55 ET
|
Vivos Therapeutics Inc.
Vivos management to present at 1:30 pm Eastern Time on March 23, 2021 HIGHLANDS RANCH, Colo., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Vivos Therapeutics, Inc. (“the Company”)...
Vivos Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering
October 09, 2020 16:55 ET
|
Vivos Therapeutics Inc.
HIGHLANDS RANCH, Colorado, Oct. 09, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Vivos Therapeutics, Inc. (“Vivos”), a medical technology company that offers novel and proprietary alternatives for...